SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 18, 1998
Uroplasty, Inc.
(Exact name of registrant as specified in its charter)
Minnesota 000-20989 41-1719250
(State or other juris- (Commission File (IRS Employer
diction of incorporation) Number) Identification No.)
2718 Summer Street N.E., Minneapolis, Minnesota 55413
(Address of principal executive offices) (Zip Code)
Registrant`s telephone number, including area code: (612) 378-1180
Not applicable
(Former name or former address, if changed since last report)
Item 5. Other Events.
UROPLASTY, INC. ANNOUNCES CONCLUSION OF PRIVATE PLACEMENT
Thursday, June 18, 1998
Uroplasty, Inc., Minneapolis, Minnesota, announced today that it had
completed a private placement of its common stock raising approximately
$4,000,000 in gross proceeds.
The securities were sold pursuant to an exemption from registration and
contain certain registration rights.
This announcement shall not constitute an offer to sell or the solicitation
of an offer to buy nor shall there be any sale of these securities in any
State in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such State.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
UROPLASTY, INC.
Dated: June 18, 1998 By: /s/ Daniel G. Holman
Daniel G. Holman, President, CEO
